
brief_title: Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma Sense3
official_title:  Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
brief_summary:
 This study aimed to prove the efficacy and safety of the use of imiquimod 5% cream in the periorbital region.
inclusion_criteria:
 - Patients whose injuries were confirmed by anatomical and pathological study (periocular superficial basal cell carcinoma). - Patients with clinical counter indication for reconstructive surgery (high surgical risk). - Patients who have refused a restorative surgery. (aesthetic reasons) - Patients who have signed the free and informed consent.
exclusion_criteria:
 - Patients who have a hypersensitivity reaction to the formula components. - Children under 12 years of age. - Pregnant and breastfeeding women. - Patients whose injury was not confirmed by anatomical and pathological study. - Individuals with previous autoimmune or inflammatory disease. - Patients who have refused to sign the free and informed term of consent.
===============

Study number 33

study_id:  